Intermittent alternating magnetic fields diminish metal-associated biofilm in vivo

• Published in: Scientific reports Vol. 13; no. 1; p. 22456
• Main Authors: Shaikh, Sumbul, Lapin, Norman A., Prasad, Bibin, Sturge, Carolyn R., Pybus, Christine, Pifer, Reed, Wang, Qi, Evers, Bret M., Chopra, Rajiv, Greenberg, David E.
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 17.12.2023; Nature Publishing Group; Nature Portfolio
• Subjects: 631/326; 631/326/2522; 631/326/46; 631/57; 631/57/1464; Anti-Bacterial Agents - pharmacology; Anti-Bacterial Agents - therapeutic use; Antibiotics; Biofilms; Humanities and Social Sciences; Humans; Joint diseases; Magnetic Fields; Metals; Morbidity; multidisciplinary; Prosthesis-Related Infections - drug therapy; Science; Science (multidisciplinary); Staphylococcus aureus; Transplants & implants
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-023-49660-7

Prosthetic joint infection (PJI) is a complication of arthroplasty that results in significant morbidity. The presence of biofilm makes treatment difficult, and removal of the prosthesis is frequently required. We have developed a non-invasive approach for biofilm eradication from metal implants using intermittent alternating magnetic fields (iAMF) to generate targeted heating at the implant surface. The goal of this study was to determine whether iAMF demonstrated efficacy in an in vivo implant biofilm infection model. iAMF combined with antibiotics led to enhanced reduction of biofilm on metallic implants in vivo compared to antibiotics or untreated control. iAMF-antibiotic combinations resulted in a > 1 − log further reduction in biofilm burden compared to antibiotics or iAMF alone. This combination effect was seen in both S. aureus and P. aeruginosa and seen with multiple antibiotics used to treat infections with these pathogens. In addition, efficacy was temperature dependent with increasing temperatures resulting in a greater reduction of biofilm. Tissue damage was limited (< 1 mm from implant-tissue interface). This non-invasive approach to eradicating biofilm could serve as a new paradigm in treating PJI.